New Zealand - English - Ministry for Primary Industries

schering-plough animal health limited - clostridium septicum toxoid; clostridium tetani toxoid; clostridium perfringens type d toxoid; clostridium novyi type b toxoid/cells; clostridium chauvoei toxoid/cells - clostridium septicum toxoid 0 vaccine; clostridium tetani toxoid 0 vaccine; clostridium perfringens type d toxoid 0 vaccine; clostridium novyi type b toxoid/cells 0 vaccine; clostridium chauvoei toxoid/cells 0 vaccine - vaccine

New Zealand - English - Ministry for Primary Industries

schering-plough animal health limited - gonadotrophin (gnrf poly albumin) - gonadotrophin (gnrf poly albumin) 0.3 thou iu/ml - endocrine agent (hormone)

New Zealand - English - Ministry for Primary Industries

schering-plough animal health limited - dexamethasone - dexamethasone 2 g/litre - endocrine agent (hormone)

New Zealand - English - Ministry for Primary Industries

schering-plough animal health limited - leptospira interrogans serovar hardjoprajitno; leptospira interrogans serovar pomona - leptospira interrogans serovar hardjoprajitno 0 vaccine; leptospira interrogans serovar pomona 0 vaccine - vaccine

New Zealand - English - Ministry for Primary Industries

schering-plough animal health limited - gonadotrophin (gnrf poly albumin) - gonadotrophin (gnrf poly albumin) 1 thou iu/ml - endocrine agent (hormone)

New Zealand - English - Ministry for Primary Industries

schering-plough animal health limited - cloprostenol sodium - cloprostenol sodium 0.25 g/litre - endocrine agent (hormone)

New Zealand - English - Ministry for Primary Industries

schering-plough animal health limited - oxytetracycline - oxytetracycline 100 g/litre - antibiotic

New Zealand - English - Ministry for Primary Industries

schering-plough animal health limited - cephalonium - cephalonium 83.3 g/kg - antibiotic

Australia - English - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - temozolomide, quantity: 250 mg - capsule, hard - excipient ingredients: sodium lauryl sulfate; lactose; stearic acid; gelatin; titanium dioxide; sodium starch glycollate; tartaric acid; colloidal anhydrous silica; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; shellac; iron oxide black; simethicone; strong ammonia solution; potassium hydroxide - temodal capsules are indicated for the treatment of patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment; recurrence of anaplastic astrocytoma and glioblastoma multiforme following standard therapy. temodal capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - temozolomide, quantity: 100 mg - capsule, hard - excipient ingredients: tartaric acid; sodium lauryl sulfate; iron oxide red; lactose; colloidal anhydrous silica; stearic acid; gelatin; sodium starch glycollate; titanium dioxide; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; shellac; iron oxide black; simethicone; strong ammonia solution; potassium hydroxide - temodal capsules are indicated for the treatment of patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment; recurrence of anaplastic astrocytoma and glioblastoma multiforme following standard therapy. temodal capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma.